世界の神経筋遮断薬市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP07207)
◆英語タイトル:Global Neuromuscular Blocking Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP07207
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月23日(※2024年版があります。お問い合わせください。)
◆ページ数:102
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、神経筋遮断薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。神経筋遮断薬の種類別市場規模(非分極剤、脱分極剤)、用途別市場規模(病院薬局、小売薬局、オンライン薬局、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Hikma Pharmaceuticals、Bayer、Merck、GSK、Novartis、AbbVie、Pfizer
・地域別グローバル市場分析 2015年-2020年
・神経筋遮断薬の北米市場(アメリカ、カナダ、メキシコ)
・神経筋遮断薬のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・神経筋遮断薬のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・神経筋遮断薬の南米市場(ブラジル、アルゼンチン)
・神経筋遮断薬の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:非分極剤、脱分極剤
・用途別分析:病院薬局、小売薬局、オンライン薬局、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The Neuromuscular Blocking Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Neuromuscular Blocking Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Neuromuscular Blocking Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Neuromuscular Blocking Drug market has been segmented into
Non-polarizing Agents
Depolarizing Agents

By Application, Neuromuscular Blocking Drug has been segmented into:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Neuromuscular Blocking Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Neuromuscular Blocking Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neuromuscular Blocking Drug market.

The report offers in-depth assessment of the growth and other aspects of the Neuromuscular Blocking Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Neuromuscular Blocking Drug Market Share Analysis
Neuromuscular Blocking Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neuromuscular Blocking Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neuromuscular Blocking Drug sales, revenue and market share for each player covered in this report.

The major players covered in Neuromuscular Blocking Drug are:
Hikma Pharmaceuticals
Bayer
Merck
GSK
Novartis
AbbVie
Pfizer

Among other players domestic and global, Neuromuscular Blocking Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neuromuscular Blocking Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neuromuscular Blocking Drug, with price, sales, revenue and global market share of Neuromuscular Blocking Drug in 2018 and 2019.
Chapter 3, the Neuromuscular Blocking Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neuromuscular Blocking Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Neuromuscular Blocking Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Neuromuscular Blocking Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Neuromuscular Blocking Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neuromuscular Blocking Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Non-polarizing Agents
1.2.3 Depolarizing Agents
1.3 Market Analysis by Application
1.3.1 Overview: Global Neuromuscular Blocking Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Overview of Global Neuromuscular Blocking Drug Market
1.4.1 Global Neuromuscular Blocking Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Hikma Pharmaceuticals
2.1.1 Hikma Pharmaceuticals Details
2.1.2 Hikma Pharmaceuticals Major Business
2.1.3 Hikma Pharmaceuticals SWOT Analysis
2.1.4 Hikma Pharmaceuticals Product and Services
2.1.5 Hikma Pharmaceuticals Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer SWOT Analysis
2.2.4 Bayer Product and Services
2.2.5 Bayer Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK SWOT Analysis
2.4.4 GSK Product and Services
2.4.5 GSK Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business
2.6.3 AbbVie Product and Services
2.6.4 AbbVie Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Product and Services
2.7.4 Pfizer Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Neuromuscular Blocking Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Neuromuscular Blocking Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Neuromuscular Blocking Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Neuromuscular Blocking Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Neuromuscular Blocking Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Neuromuscular Blocking Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Neuromuscular Blocking Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
4.3 Europe Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
4.5 South America Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Neuromuscular Blocking Drug Sales, Revenue and Market Share by Country
5.1.1 North America Neuromuscular Blocking Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Neuromuscular Blocking Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
5.3 Canada Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Neuromuscular Blocking Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Neuromuscular Blocking Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Neuromuscular Blocking Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
6.3 UK Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
6.4 France Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
6.5 Russia Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
6.6 Italy Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Neuromuscular Blocking Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Neuromuscular Blocking Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Neuromuscular Blocking Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
7.3 Japan Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
7.4 Korea Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
7.5 India Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
7.7 Australia Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Neuromuscular Blocking Drug Sales, Revenue and Market Share by Country
8.1.1 South America Neuromuscular Blocking Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Neuromuscular Blocking Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Neuromuscular Blocking Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Neuromuscular Blocking Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Neuromuscular Blocking Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Neuromuscular Blocking Drug Sales and Market Share by Type (2015-2020)
10.2 Global Neuromuscular Blocking Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Neuromuscular Blocking Drug Price by Type (2015-2020)
11 Global Neuromuscular Blocking Drug Market Segment by Application
11.1 Global Neuromuscular Blocking Drug Sales Market Share by Application (2015-2020)
11.2 Global Neuromuscular Blocking Drug Revenue Market Share by Application (2015-2020)
11.3 Global Neuromuscular Blocking Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Neuromuscular Blocking Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Neuromuscular Blocking Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Neuromuscular Blocking Drug Market Forecast (2021-2025)
12.2.2 Europe Neuromuscular Blocking Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Neuromuscular Blocking Drug Market Forecast (2021-2025)
12.2.4 South America Neuromuscular Blocking Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Neuromuscular Blocking Drug Market Forecast (2021-2025)
12.3 Neuromuscular Blocking Drug Market Forecast by Type (2021-2025)
12.3.1 Global Neuromuscular Blocking Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Neuromuscular Blocking Drug Market Share Forecast by Type (2021-2025)
12.4 Neuromuscular Blocking Drug Market Forecast by Application (2021-2025)
12.4.1 Global Neuromuscular Blocking Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Neuromuscular Blocking Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【掲載企業】

Hikma Pharmaceuticals、Bayer、Merck、GSK、Novartis、AbbVie、Pfizer

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の神経筋遮断薬市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Neuromuscular Blocking Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。